Cerulean Pharma Inc. To Present At JMP Securities Healthcare Conference
Published: Jun 17, 2014
CAMBRIDGE, Mass., June 17, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, J.D., Senior Vice President and Chief Business Officer, will present at the JMP Securities Healthcare Conference in New York City on Tuesday, June 24, 2014, at 3:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.